Theraclion SA (ALTHE) Stock Statistics & Valuation Metrics

Theraclion SA has a market cap or net worth of €47.80M. The enterprise value is €39.38M.

Theraclion SA has 73,123,314 shares outstanding. The number of shares has decreased by -2.65% in one year.

Theraclion SA’s return on equity (ROE) is 50.50K and return on invested capital (ROIC) is -76.99%.

The current PE Ratio of Theraclion SA is ―. Theraclion SA’s PEG ratio is -0.06.

In the last 12 months, Theraclion SA had revenue of 830.00K and earned -5.76M in profits. Earnings per share was -0.12.

In the last 12 months, operating cash flow was -4.96M and capital expenditures -267.65K, giving a free cash flow of -5.23M billion.

Theraclion SA pays an annual dividend of ―, resulting in a dividend yield of ―

Theraclion SA upcoming earnings date is Oct 14, 2026, TBA (Confirmed).

Theraclion SA as a current ratio of 2.21, with Debt / Equity ratio of -196.64%

In the past 12 months, Theraclion SA has paid -984.00K in taxes.

Theraclion SA EV to EBITDA ratio is -2.09, with an EV/FCF ratio of -4.11.

Theraclion SA has €3.35M in cash and marketable securities with €4.30M in debt, giving a net cash position of -€942.00K billion.

Gross margin is -528.16%, with operating margin of -838.55%, and net profit margin of -693.61%.

The average price target for Theraclion SA is ―, which is 11.43% higher than the current price. The consensus rating is ―